These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 7810947)

  • 1. Omeprazole therapy in resistant reflux disease.
    Wright JM; Sarich TC
    Ann Intern Med; 1995 Feb; 122(3):236; author reply 236-7. PubMed ID: 7810947
    [No Abstract]   [Full Text] [Related]  

  • 2. Omeprazole therapy in resistant reflux disease.
    Waldum HL; Brenna E
    Ann Intern Med; 1995 Feb; 122(3):236; author reply 236-7. PubMed ID: 7888009
    [No Abstract]   [Full Text] [Related]  

  • 3. Medical treatment of reflux esophagitis.
    Olbe L; Lundell L
    Hepatogastroenterology; 1992 Aug; 39(4):322-4. PubMed ID: 1427576
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comment on the contribution: "Effect of omeprazole on serum gastrin levels: influence of age and sex" by Koop et al].
    Miederer SE
    Z Gastroenterol; 1991 Apr; 29(4):177-8. PubMed ID: 1866976
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of omeprazole on serum gastrin levels: influence of age and sex.
    Koop H; Naumann-Koch C; Arnold R
    Z Gastroenterol; 1990 Nov; 28(11):603-5. PubMed ID: 1981116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term treatment with omeprazole for refractory reflux esophagitis: efficacy and safety.
    Klinkenberg-Knol EC; Festen HP; Jansen JB; Lamers CB; Nelis F; Snel P; Lückers A; Dekkers CP; Havu N; Meuwissen SG
    Ann Intern Med; 1994 Aug; 121(3):161-7. PubMed ID: 8017742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Omeprazole, hypergastrinemia, and gastric carcinoid tumors.
    Freston JW
    Ann Intern Med; 1994 Aug; 121(3):232-3. PubMed ID: 8017751
    [No Abstract]   [Full Text] [Related]  

  • 8. Increasing concerns about chronic proton pump inhibitor use.
    Svoboda AC
    J Clin Gastroenterol; 2001 Jul; 33(1):3-7. PubMed ID: 11418781
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy and safety of omeprazole in the long-term treatment of peptic ulcer and reflux oesophagitis resistant to ranitidine.
    Brunner GH; Lamberts R; Creutzfeldt W
    Digestion; 1990; 47 Suppl 1():64-8; discussion 76. PubMed ID: 2093018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inter-relationship between serum gastrin levels, gastric mucosal histology and gastric endocrine cell growth.
    Creutzfeldt W; Lamberts R
    Digestion; 1992; 51 Suppl 1():76-81. PubMed ID: 1397748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of lansoprazole in the treatment of erosive reflux esophagitis. The Lansoprazole Group.
    Castell DO; Richter JE; Robinson M; Sontag SJ; Haber MM
    Am J Gastroenterol; 1996 Sep; 91(9):1749-57. PubMed ID: 8792693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Omeprazole and high dose ranitidine in the treatment of refractory reflux oesophagitis.
    Cucchiara S; Minella R; Iervolino C; Franco MT; Campanozzi A; Franceschi M; D'Armiento F; Auricchio S
    Arch Dis Child; 1993 Dec; 69(6):655-9. PubMed ID: 8285777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term safety and efficacy of omeprazole in gastro-oesophageal reflux disease.
    Armstrong D
    Lancet; 2000 Aug; 356(9230):610-2. PubMed ID: 10968429
    [No Abstract]   [Full Text] [Related]  

  • 14. Lansoprazole versus omeprazole in the treatment of reflux esophagitis.
    Vcev A; Stimac D; Vceva A; Rubinić M; Ivandić A; Ivanis N; Horvat D; Volarić M; Karner I
    Acta Med Croatica; 1997; 51(3):171-4. PubMed ID: 9248117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of CYP2C19 polymorphism on the safety and efficacy of omeprazole in Japanese patients with recurrent reflux oesophagitis.
    Ohkusa T; Maekawa T; Arakawa T; Nakajima M; Fujimoto K; Hoshino E; Mitachi Y; Hamada S; Mine T; Kawahara Y; Nagai T; Aoyama N; Yoshida N; Tadokoro K; Chida N; Konda Y; Seno H; Shimatani T; Inoue M; Sato N
    Aliment Pharmacol Ther; 2005 Jun; 21(11):1331-9. PubMed ID: 15932363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy.
    Sontag SJ; Kogut DG; Fleischmann R; Campbell DR; Richter J; Robinson M; McFarland M; Sabesin S; Lehman GA; Castell D
    Am J Gastroenterol; 1997 Mar; 92(3):429-37. PubMed ID: 9068463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of omeprazole in healing and prevention of reflux disease.
    Klinkenberg-Knol EC
    Hepatogastroenterology; 1992 Feb; 39 Suppl 1():27-30. PubMed ID: 1577392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guaiacol -- a new compound in the treatment of gastro-oesophageal reflux?
    Heatley RV; Evans BK; Rhodes J; Atkinson M
    Gut; 1982 Dec; 23(12):1044-7. PubMed ID: 7173715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlled clinical trials of omeprazole in the long-term management of reflux disease.
    Hetzel DJ
    Digestion; 1992; 51 Suppl 1():35-42. PubMed ID: 1397745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prevention of recurrent erosive reflux esophagitis].
    Müller P; Simon B
    Fortschr Med; 1997 Oct; 115(30):46-7. PubMed ID: 9453943
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.